🇺🇸 FDA
Pipeline program

SNS-301

SNS-301-2-2

Phase 2 small_molecule terminated

Quick answer

SNS-301 for Squamous Cell Carcinoma of the Head and Neck is a Phase 2 program (small_molecule) at Sensei Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Sensei Biotherapeutics
Indication
Squamous Cell Carcinoma of the Head and Neck
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials